CSTLCastle Biosciences, Inc.

$772M

Q1 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$17M+99.8% YoY

Gross Profit

$15M86.3% margin

Operating Income

$1M5.9% margin

Net Income

$570,0003.3% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

-1.2%

Cash Flow

Operating Cash Flow

-$251,000

Free Cash Flow

-$751,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$120M

Total Liabilities

$32M

Stockholders' Equity

$88M

Cash & Equivalents

$99M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$9M	+99.8%
Gross Profit	$15M	$7M	+111.1%
Operating Income	$1M	-$321,444	+422.3%
Net Income	$570,000	-$1M	+142.0%

CSTL Q1 2020 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena